Regeneron Pharmaceuticals Inc (REGN)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	14,185,900	13,812,700	13,436,900	13,029,000	13,044,200	13,025,200	12,601,200	12,306,100	12,113,500	13,654,100	14,171,800	16,451,800	16,014,400	13,499,700	12,328,800	9,147,000	8,455,000	8,201,600	7,974,500	7,957,900
Property, plant and equipment	US$ in thousands	4,008,500	4,439,200	4,305,900	4,225,500	3,540,700	4,006,100	3,922,600	3,880,900	3,142,700	3,704,200	3,637,700	3,556,400	3,482,200	3,395,700	3,358,500	3,262,600	3,221,600	3,138,300	3,031,400	2,944,600
Fixed asset turnover		3.54	3.11	3.12	3.08	3.68	3.25	3.21	3.17	3.85	3.69	3.90	4.63	4.60	3.98	3.67	2.80	2.62	2.61	2.63	2.70

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $14,185,900K ÷ $4,008,500K
= 3.54

The fixed asset turnover ratio for Regeneron Pharmaceuticals Inc has shown a fluctuating trend over the past few years, ranging from 2.61 to 4.63. The ratio measures how efficiently the company is utilizing its fixed assets to generate revenue. A higher ratio indicates that the company is generating more revenue per dollar of fixed assets.

From March 31, 2020, to December 31, 2021, the fixed asset turnover ratio consistently increased, reflecting improved efficiency in utilizing fixed assets. However, from March 31, 2022, to December 31, 2024, the ratio fluctuated within the range of 3.08 to 3.68. This may indicate some variability in the company's asset utilization efficiency during this period.

Overall, the company's fixed asset turnover ratio has generally been healthy, suggesting effective management of fixed assets to generate revenue. It is important for investors and analysts to monitor this ratio over time to assess the company's operational efficiency and ability to generate revenue from its fixed assets.